Time-lapse mapping of cortical changes in schizophrenia with different treatments.
暂无分享,去创建一个
J. Lieberman | G. Bartzokis | A. Toga | P. Thompson | M. Tohen | R. Hamer | K. Hayashi | J. Geaga | P. Lu | A. Klunder | Michael S. Hong | J. McEvoy | D. Perkins | N. Edwards | Michael Yu | C. Charles | G. Tollefson | J. Mcevoy
[1] W T Carpenter,et al. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.
[2] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[3] L. DeLisi,et al. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients , 1987, Biological Psychiatry.
[4] J S Fowler,et al. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.
[5] S. Anderson,et al. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. , 1994, Journal of psychiatric research.
[6] D. Louis Collins,et al. Automatic 3‐D model‐based neuroanatomical segmentation , 1995 .
[7] Manzar Ashtari,et al. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.
[8] J. Coyle,et al. Tardive dyskinesia and substrates of energy metabolism in CSF. , 1995, The American journal of psychiatry.
[9] Alan C. Evans,et al. Automatic 3D Regional MRI Segmentation and Statistical Probability Anatomy Maps , 1996 .
[10] D R Medoff,et al. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.
[11] L. DeLisi,et al. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia , 1997, Psychiatry Research: Neuroimaging.
[12] E. Leibenluft,et al. Agreement between face-to-face and telephone-administered mood ratings in patients with rapid cycling bipolar disorder , 1997, Psychiatry Research.
[13] J. Bloomquist,et al. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia , 1998, Brain Research.
[14] Alan C. Evans,et al. A method for identifying geometrically simple surfaces from three-dimensional images , 1998 .
[15] Tyrone D. Cannon,et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.
[16] B. Woods. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. , 1998, The American journal of psychiatry.
[17] Jeffrey A Lieberman,et al. Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective , 1999, Biological Psychiatry.
[18] P. Goldman-Rakic,et al. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure , 1999, Biological Psychiatry.
[19] L. Grossman,et al. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms , 2000, British Journal of Psychiatry.
[20] S. Kapur,et al. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. , 2000, Journal of psychiatry & neuroscience : JPN.
[21] R. Hoffman,et al. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. , 2000, Archives of general psychiatry.
[22] G. Duncan,et al. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. , 2000, The Journal of pharmacology and experimental therapeutics.
[23] J. Lieberman,et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches , 2001, Biological Psychiatry.
[24] J. Rapoport,et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] K O Lim,et al. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.
[26] S. Heckers,et al. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia , 2001, Biological Psychiatry.
[27] R. Leahy,et al. Magnetic Resonance Image Tissue Classification Using a Partial Volume Model , 2001, NeuroImage.
[28] J. Kane,et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. , 2002, The Journal of clinical psychiatry.
[29] Daniel R Weinberger,et al. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.
[30] Lorena Hsu,et al. Prevalence and Incidence Studies of Schizophrenic Disorders: A Systematic Review of the Literature , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[31] K. Nylen,et al. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration , 2002, Brain Research.
[32] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[33] Tyrone D. Cannon,et al. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. , 2003, Schizophrenia bulletin.
[34] Jim Mintz,et al. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study , 2003, Biological Psychiatry.
[35] J. Lieberman,et al. Olanzapine and Clozapine Increase the GABAergic Neuroactive Steroid Allopregnanolone in Rodents , 2003, Neuropsychopharmacology.
[36] Patrick R Hof,et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.
[37] John Suckling,et al. For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .
[38] Kiralee M. Hayashi,et al. Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[39] Suzanne E. Welcome,et al. Mapping cortical change across the human life span , 2003, Nature Neuroscience.
[40] Vincent Magnotta,et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.
[41] J. Lieberman,et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. , 2003, The American journal of psychiatry.
[42] Nancy C. Andreasen,et al. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent , 2004, Schizophrenia Research.
[43] Kiralee M. Hayashi,et al. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia , 2004, NeuroImage.
[44] J. Quevedo,et al. Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain , 2004, Neuroscience Letters.
[45] A. Deutch,et al. Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat , 2004, Neuropsychopharmacology.
[46] Thomas F. Nugent,et al. Dynamic mapping of human cortical development during childhood through early adulthood. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Lieberman,et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. , 2004, The American journal of psychiatry.
[48] V. Parikh,et al. Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol , 2004, Neuroscience Letters.
[49] A. Peters,et al. Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. , 2004, Cerebral cortex.
[50] Tyrone D. Cannon,et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. , 2005, Archives of general psychiatry.
[51] V. Molina. Structural effects of atypical antipsychotics: Implications for the meaning of cortical volume deficit in schizophrenia , 2005 .
[52] Kiralee M. Hayashi,et al. Abnormal Cortical Complexity and Thickness Profiles Mapped in Williams Syndrome , 2005, The Journal of Neuroscience.
[53] Marek Kubicki,et al. Evidence for white matter abnormalities in schizophrenia , 2005, Current opinion in psychiatry.
[54] Paul J. Harrison. Neuropathology of schizophrenia , 2005 .
[55] Kiralee M. Hayashi,et al. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Lieberman,et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.
[57] R. Woods,et al. Cortical Thinning in Cingulate and Occipital Cortices in First Episode Schizophrenia , 2005, Biological Psychiatry.
[58] J. Potash,et al. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: Trouble at the borders , 2005, International review of psychiatry.
[59] John Suckling,et al. Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study , 2005, Neuropsychopharmacology.
[60] Manzar Ashtari,et al. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. , 2005, The American journal of psychiatry.
[61] Eve C. Johnstone,et al. Grey matter changes over time in high risk subjects developing schizophrenia , 2005, NeuroImage.
[62] Zhuoxin Sun,et al. The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.
[63] R. S. Kahn,et al. Brain volume changes in the first year of illness and 5-year outcome of schizophrenia , 2006, British Journal of Psychiatry.
[64] John H. Gilmore,et al. Apoptotic mechanisms and the synaptic pathology of schizophrenia , 2006, Schizophrenia Research.
[65] P. Renshaw,et al. Regional cerebral cortical thinning in bipolar disorder. , 2006, Bipolar disorders.
[66] Norbert Schuff,et al. Longitudinal stability of MRI for mapping brain change using tensor-based morphometry , 2006, NeuroImage.
[67] Adrian Preda,et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. , 2006, The American journal of psychiatry.
[68] Kiralee M. Hayashi,et al. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. , 2006, Archives of general psychiatry.
[69] Michael F. Green,et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. , 2007, Archives of general psychiatry.
[70] J. Lieberman. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. , 2007, The Journal of clinical psychiatry.
[71] Arthur W Toga,et al. Relationships between IQ and regional cortical gray matter thickness in healthy adults. , 2007, Cerebral cortex.
[72] Paul M. Thompson,et al. 3D pattern of brain abnormalities in Williams syndrome visualized using tensor-based morphometry , 2007, NeuroImage.
[73] Agatha D. Lee,et al. Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. , 2007, Cerebral cortex.
[74] Kiralee M. Hayashi,et al. Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar Disorder , 2007, Biological Psychiatry.
[75] R. Kahn,et al. Progressive brain changes in schizophrenia. , 2007, Schizophrenia bulletin.
[76] Hui-Dong Wang,et al. Dopamine Depletion of the Prefrontal Cortex Induces Dendritic Spine Loss: Reversal by Atypical Antipsychotic Drug Treatment , 2008, Neuropsychopharmacology.
[77] Eugene S. Edgington,et al. Randomization Tests , 2011, International Encyclopedia of Statistical Science.